Literature DB >> 25641031

Interstitial Fluid Pressure Correlates Clinicopathological Factors of Lung Cancer.

Takeshi Mori1, Takamasa Koga, Hidekatsu Shibata, Koei Ikeda, Kenji Shiraishi, Makoto Suzuki, Ken-ichi Iyama.   

Abstract

PURPOSE: Solid tumors show increased interstitial fluid pressure (IFP), which correlates to a number of pathophysiological features of tumors. There have been no reports on the usefulness of measuring IFP in lung cancer. The aim of this study was to examine the relationship between IFP and the clinicopathological characteristics of lung cancer.
METHODS: IFP was measured prospectively in 215 patients with 219 lesions showing solid or part-solid appearance. Four patients with double lung cancer were excluded from the analysis, resulting in 211 patients with lung cancer being analyzed for the correlation between IFP and computed tomography (CT) appearance, size, Tumor-node-metastasis (TNM) classification, maximal standardized uptake value (SUVmax), histological type, tumor grade, pleural and vessel invasion, Ki-67 index, and recurrence-free survival (RFS).
RESULTS: The mean IFP was 8.5 mmHg; IFP was significantly correlated with the tumor size, SUVmax, TNM, vessel and pleural invasion, and Ki-67 index. Low IFP was associated with a better RFS compared to high IFP. Multivariate analysis did not select IFP as independent prognostic factor. In subgroup analysis of patients with adenocarcinoma, IFP was selected as independent one.
CONCLUSIONS: IFP correlates clinicopathological factors of lung cancer. IFP might be used as a prognostic factor for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25641031      PMCID: PMC4989964          DOI: 10.5761/atcs.oa.14-00208

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  20 in total

Review 1.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.

Authors:  K Aukland; R K Reed
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

2.  Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.

Authors:  M Milosevic; A Fyles; D Hedley; M Pintilie; W Levin; L Manchul; R Hill
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 3.  High interstitial fluid pressure - an obstacle in cancer therapy.

Authors:  Carl-Henrik Heldin; Kristofer Rubin; Kristian Pietras; Arne Ostman
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

4.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

5.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

6.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

7.  Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2.

Authors:  Peng-Bo Deng; Cheng-Ping Hu; Zeng Xiong; Hua-Ping Yang; Yuan-Yuan Li
Journal:  Chin J Nat Med       Date:  2013-05

8.  Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts.

Authors:  Bao-Quan Lin; Zhi-Yong Zeng; Sheng-Sheng Yang; Cong-Wen Zhuang
Journal:  Lung Cancer       Date:  2012-11-28       Impact factor: 5.705

9.  Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).

Authors:  Chandrajit P Raut; Yves Boucher; Dan G Duda; Jeffrey A Morgan; Richard Quek; Marek Ancukiewicz; Johanna Lahdenranta; J Paul Eder; George D Demetri; Rakesh K Jain
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

10.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; C Mascaux; T Berghmans; P Lothaire; A-P Meert; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

View more
  2 in total

Review 1.  Mechanical Forces in Tumor Angiogenesis.

Authors:  Matthew R Zanotelli; Cynthia A Reinhart-King
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

2.  Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure.

Authors:  Steven K Libutti; Lawrence Tamarkin; Naris Nilubol
Journal:  Oncotarget       Date:  2018-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.